Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-29

Clinical Trial Update: Cognitive Impairment Related to Atrial Fibrillation Prevention Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial update related to cognitive impairment in patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Sao Paulo | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED